Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

被引：0
作者：
Lennart Tonneijck
Mark M. Smits
Marcel H. A. Muskiet
Trynke Hoekstra
Mark H. H. Kramer
A. H. Jan Danser
Michaela Diamant
Jaap A. Joles
Daniël H. van Raalte
机构：
[1] VU University Medical Center Amsterdam,Department of Internal Medicine/Diabetes Center
[2] VU University Amsterdam,Department of Health Sciences and the EMGO Institute for Health and Care Research
[3] VU University Medical Center,Department of Epidemiology and Biostatistics
[4] Erasmus University Medical Center,Division of Pharmacology and Vascular Medicine, Department of Internal Medicine
[5] University Medical Center,Department of Nephrology and Hypertension
来源：
Diabetologia | 2016年 / 59卷
关键词：
Diabetes; Exenatide; Glomerular filtration rate; Glomerular hyperfiltration; GLP-1 receptor agonist; Glucagon-like peptide-1; Renal function; Renal haemodynamics; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1412 / 1421
页数：9
相关论文
共 125 条
  • [51] Kataoka HU(undefined)undefined undefined undefined undefined-undefined
  • [52] Von Scholten BJ(undefined)undefined undefined undefined undefined-undefined
  • [53] Lajer M(undefined)undefined undefined undefined undefined-undefined
  • [54] Goetze JP(undefined)undefined undefined undefined undefined-undefined
  • [55] von Scholten BJ(undefined)undefined undefined undefined undefined-undefined
  • [56] Hansen TW(undefined)undefined undefined undefined undefined-undefined
  • [57] Goetze JP(undefined)undefined undefined undefined undefined-undefined
  • [58] Imamura S(undefined)undefined undefined undefined undefined-undefined
  • [59] Hirai K(undefined)undefined undefined undefined undefined-undefined
  • [60] Hirai A(undefined)undefined undefined undefined undefined-undefined
12345678910